Vimarsana
Biggest News Aggregation in the World

Analyst Will News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Analyst Will. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Analyst Will Today - Breaking & Trending Today

JLL Capital Markets Secures $67 Million in Refinancing for 100-Unit Mid-Rise Apartment Community in Edina, Minnesota - Vimarsana News

JLL Capital Markets Secures $67 Million in Refinancing for 100-Unit Mid-Rise Apartment Community in Edina, Minnesota

CHICAGO, IL - JLL Capital Markets announced that it has arranged a $67 million refinancing for Nolan Mains, a 100-unit, mixed-used, mid-rise apartment community located in the 50th and France neighborhood of Edina, Minnesota. JLL worked on behalf of the borrower, Buhl Investors and Saturday Properties, to secure the Fannie Mae loan. The loan will be serviced by JLL Real Estate Capital, LLC, a Fannie Mae DUS lender. Built in 2019, Nolan Main was a public-private partnership with the City of...

$67M in refinancing secured for a Minnesota multi-housing community - Vimarsana News

$67M in refinancing secured for a Minnesota multi-housing community

MINNEAPOLIS, March 16, 2022 – JLL Capital Markets announced that it has arranged a $67 million refinancing for Nolan Mains, a 100-unit, mixed-used, mid-rise apartment community located in the 50th and France neighborhood of Edina, Minnesota.

$67M in refinancing secured for a Minnesota multi-housing community - Vimarsana News

$67M in refinancing secured for a Minnesota multi-housing community

JLL Capital Markets has arranged a $67M refinancing for Nolan Mains, a mixed-used, mid-rise apartment community located in Edina, Minnesota.

Source: jll.com
EDISON Publishes Healthcare QuickView on Cannabics Pharmaceuticals: CNBX - Vimarsana News

EDISON Publishes Healthcare QuickView on Cannabics Pharmaceuticals: CNBX

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...